Bibliographie

 

Références utilisées pour la rédaction du texte original et l’élaboration de l’algorithme

- Donald A. Henderson; Thomas V. Inglesby; John G. Bartlett; et al. Smallpox as a Biological Weapon: Medical and Public Health Management. JAMA. 1999;281(22):2127-2137

- Zygmunt F. Dembek. Medical aspects of Biological Warfare. Office of The Surgeon General ; Borden Institute. 2007 ;  607pp

- Debord T., Binder P., Salomon J. et Roué R. Les armes biologiques Topique 2002 ;4 : 93-101

- CDC Emergency preparedness and response. http://www.bt.cdc.gov/ consulté le 20/04/10

- Christine Gosden and Derek Gardener. Weapons of mass destruction—threats and responses. BMJ 2005;331;397-400

- R Darling, C Catlett, K Huebner, D Jarrett Threats in bioterrorism I: CDC category A agents. Emerg Med Clin N Am 20 (2002) 273–309

- G.J. Moran Threats in bioterrorism II: CDC category B and C agents. Emerg Med Clin N Am 20 (2002):311–330

- Thomas V. Inglesby; Tara O'Toole; Donald A. Henderson; et al. Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management. JAMA. 2002;287(17):2236-2252

- Stephen S. Arnon; Robert Schechter; Thomas V. Inglesby; et al. Botulinum Toxin as a Biological Weapon: Medical and Public Health Management. JAMA. 2001;285(8):1059-1070

- Thomas V. Inglesby; David T. Dennis; Donald A. Henderson; et al. Plague as a Biological Weapon: Medical and Public Health Management. JAMA. 2000;283(17):2281-2290

- David T. Dennis; Thomas V. Inglesby; Donald A. Henderson; et al.Tularemia as a Biological Weapon: Medical and Public Health Management. JAMA. 2001;285(21):2763-2773

- Luciana Borio; Thomas Inglesby; C. J. Peters; et al. Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management. JAMA, 2002;287(18):2391-2405

- N Beeching, D Dance, A Miller, R Spencer Biological warfare and bioterrorism. BMJ 2002;324;336-339

- David N Durrheim, Reinhold Muller, Vicki L Saunders, Richard Speare, John B Lowe A population survey--would Australian general practice be the first point of contact during an anthrax bioterrorism event? Aust Fam Physician (2006) vol. 35 (3) pp. 172-4

- MMWR (CDC) Recognition of Illness Associated With the Intentional Release of a Biologic Agent. JAMA (2001) vol. 286 (17) pp. 2088